Compass Therapeutics Inc. Share Price

NASDAQ: CMPX

Small Cap

$3.62

-0.07

(-2.03%)

as on September 17, 2025 at 1:29 am IST

$₹

Compass Therapeutics Inc. Stock Performance

as on September 17, 2025 at 1:29 am IST

Day's Low
Day's High
$3.6
Day's Price Range
$3.77
$3.62
0.55%
Downside
4.14%
Upside
52 Week's Low
52 Week's High
$1.27
52-Week Price Range
$4.08
$3.62
64.92%
Downside
12.71%
Upside

Compass Therapeutics Inc. share price movements today

Previous Close: $3.69
Open: $3.69
Volume: 1.1M
Day's Low - High: $3.6 - $3.77
52 Week Low - High: $1.27 - $4.08

Compass Therapeutics Inc. Historical Returns

1 Month Return: + 24.24 %
3 Month Return: + 55.7 %
1 Year Return: + 115.79 %
3 Year Return: + 20.98 %
5 Year Return: 0 %

Compass Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Compass Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$612.5M

EPS (TTM)

-0.5486

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-67.3M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Compass Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Compass Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Compass Therapeutics Inc.	BUY	$612.5M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	251.26%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	47.46%	28.09	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	0.6%	14.1	31.37%

Stock Returns calculator for Compass Therapeutics Inc. Stock including INR - Dollar returns

The Compass Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Compass Therapeutics Inc. investment value today

Current value as on today

₹2,16,563

Returns

₹1,16,563

(+116.56%)

Returns from Compass Therapeutics Inc. Stock

₹1,11,696 (+111.7%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Compass Therapeutics Inc. Stock

Based on 13 analysts

BUY

84.62%

Buy

15.38%

Hold

0.00%

Sell

Based on 13 analysts, 84.62% of analysts recommend a 'BUY' rating for Compass Therapeutics Inc.. Average target price of $13.2

Compass Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Compass Therapeutics Inc..

What analysts predicted

72.58%UPSIDE

Target Price

$13.2

Current Price

$3.62

Analyzed by

13 Analysts

Target

$13.20

Compass Therapeutics Inc. target price $13.2, a slight upside of 72.58% compared to current price of $3.62. According to 13 analysts rating.

Compass Therapeutics Inc. Stock's Interest Amongst Investors

Search interest for Compass Therapeutics Inc. Stock has decreased by -43% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:-43% versus previous 30 day period

Compass Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	2	-	0	-	-	-	-
Gross Profit	0	0	0	2	0	0	-	-	-	0
Operating Income	-9	-13	-11	-15	-12	-15	-12	-16	-17	-21
EBITDA	-9	-12	-11	-14	-12	-14	-11	-16	-17	-21
Interest Expense	1	-	-	1	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-7	-11	-9	-13	-10	-13	-10	-15	-16	-19
Income Tax Expense	-1	0	0	1	0	-	-	-	-	-
Net Income	-5	-11	-9	-13	-10	-13	-10	-15	-16	-19
Net Profit Margin	0.00%	0.00%	0.00%	-471.69%	0.00%	-1538.35%	0.00%	0.00%	0.00%	0.00%

Compass Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	0
Gross Profit	-1	-2	-2	-1	-1	-1	0
Operating Income	-38	-34	-27	-81	-41	-50	-56
EBITDA	-35	-31	-25	-29	-37	-48	-54
Interest Expense	0	1	0	0	2	-	-
Depreciation	1	2	2	1	1	1	1
Income Before Tax	-38	-34	-29	-82	-39	-42	-49
Income Tax Expense	0	0	0	0	-2	-	-
Net Income	-38	-34	-29	-82	-36	-42	-49
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-5808.82%

Compass Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-11	-9	-13	-10	-13	-10	-15	-16	-19
Operating Cash Flow	-10	-5	-12	-13	-10	-11	-9	-13	-11
Investing Cash Flow	0	17	6	-4	6	29	15	11	-6
Financing Cash Flow	3	0	0	17	0	0	0	0	-
Change in Cash	-7	11	-6	0	-4	17	6	-2	-18

Compass Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-34	-29	-82	-39	-42	-49
Operating Cash Flow	-31	-26	-19	-34	-40	-44
Investing Cash Flow	0	0	-1	-151	26	46
Financing Cash Flow	0	48	118	75	2	17
Change in Cash	-32	21	97	-109	-10	19

Global Institutional Holdings in Compass Therapeutics Inc.

Funds	Holdings
Orbimed Advisors, LLC	16.17%
TANG CAPITAL MANAGEMENT LLC	7.99%
Blackstone Inc	7.25%
MPM Oncology Impact Management LP	6.11%
Enavate Sciences GP, LLC	5.63%

See all

Insights on Compass Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, CMPX has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 1 month, CMPX stock has moved up by 24.2%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 95.5%

About Compass Therapeutics Inc.

compass therapeutics is an antibody discovery and development company focused on comprehensively drugging the tumor-immune synapse with combinations of human monoclonal antibodies, multiclonals, and engineered protein constructs. compass is industrializing antibody discovery and decentralizing biologic validation through a partnership-first mentality that leverages best-in-class technologies and top-tier academic laboratories around the world. novel scientific insights are validated and explored deeply inside our labs before compass pursues the best proprietary combinations of therapeutics into human clinical trials. in 2015, compass quietly closed a $120mm series a financing to fund our ambitious plan to build a fully-integrated biopharmaceutical company from the ground up. our investors are among the most sophisticated venture capitalists in the industry who exemplify our philosophy of building long term economic value only by delivering therapeutics with meaningful efficacy beyond

Organisation	Compass Therapeutics Inc.
Headquarters	80 Guest Street, Boston, MA, United States, 02135
Industry	Health Technology
CEO	Dr. Thomas J. Schuetz M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Compass Therapeutics Inc.

Name	Title
Dr. Minori Rosales M.D., Ph.D.	Senior VP & Head of Clinical Development
Ms. Karin Herrera B.A.	Senior VP & Head of Clinical Operations
Dr. James Kranz Ph.D.	VP and Head of Chemistry Manufacturing & Controls
Dr. Thomas J. Schuetz M.D., Ph.D.	CEO & Vice Chairman
Mr. Barry Shin J.D., M.B.A.	Chief Financial Officer
Mr. Jonathan E. Anderman J.D.	Senior VP, General Counsel & Corporate Secretary
Mr. Neil L. Lerner CPA	Senior VP & Chief Accounting Officer
Anna Gifford	Communications Manager

FAQs

What is Compass Therapeutics Inc. share price today?

Compass Therapeutics Inc. share price today is $3.62 as on September 17, 2025 at 1:29 am IST at the close of the market. Compass Therapeutics Inc. share today touched a day high of $3.77 and a low of $3.6.

What is the 52 week high and 52 week low for Compass Therapeutics Inc. share?

Compass Therapeutics Inc. share touched a 52 week high of $4.08 on February 11, 2025 and a 52 week low of $1.27 on November 18, 2024. Compass Therapeutics Inc. stock price today i.e. September 17, 2025 at 1:29 am IST is closed at $3.62,which is 11.27% down from its 52 week high and 185.04% up from its 52 week low.

What is Compass Therapeutics Inc.'s market capitalisation today?

Compass Therapeutics Inc. market capitalisation is $0.00T as on September 17, 2025 at 1:29 am IST.

How to invest in Compass Therapeutics Inc. Stock (CMPX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Compass Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Compass Therapeutics Inc. Shares that will get you 0.4144 shares as per Compass Therapeutics Inc. share price of $3.62 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Compass Therapeutics Inc. Stock (CMPX) from India?

Indian investors can start investing in Compass Therapeutics Inc. (CMPX) shares with as little as ₹88.042 or $1 (as of September 17, 2025 at 4:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Compass Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 4:40 am IST). Based on Compass Therapeutics Inc. share’s latest price of $3.62 as on September 17, 2025 at 1:29 am IST, you will get 2.7624 shares of Compass Therapeutics Inc.. Learn more about fractional shares .